Ppars, metabolic disease and atherosclerosis
- 30 November 2001
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 44 (5), 345-352
- https://doi.org/10.1006/phrs.2001.0871
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Expression of Peroxisome Proliferator-Activated Receptor α (PPARα) in Primary Cultures of Human Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1998
- The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiationBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.JCI Insight, 1996
- Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.JCI Insight, 1995
- Modulation of Lipoprotein B Binding to the LDL Receptor by Exogenous Lipids and Apolipoproteins CI, CII, CIII, and EArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Low density lipoprotein density and composition in hypercholesterolaemic men treated with HMG CoA reductase inhibitors and gemfibrozilJournal of Internal Medicine, 1991
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990
- Effects of fenofibrate on high and low density lipoprotein metabolism in heterozygous familial hypercholesterolemiaAtherosclerosis, 1985